SYNGENE INTERNATIONAL
|
SYNGENE INTERNATIONAL Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 12.69 | 11.57 | 9.88 | 10.12 | 10.30 |
| CEPS(Rs) | 23.28 | 20.70 | 17.60 | 16.99 | 15.79 |
| DPS(Rs) | 1.25 | 1.25 | 1.00 | - | - |
| Book NAV/Share(Rs) | 104.19 | 88.51 | 80.09 | 68.61 | 53.42 |
| Tax Rate(%) | 17.85 | 21.77 | 18.29 | 13.70 | 20.27 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 29.05 | 29.18 | 28.43 | 29.90 | 29.99 |
| EBIT Margin(%) | 19.13 | 19.98 | 19.53 | 22.75 | 27.41 |
| Pre Tax Margin(%) | 17.78 | 18.57 | 18.60 | 21.48 | 25.69 |
| PAT Margin (%) | 14.60 | 14.53 | 15.20 | 18.54 | 20.48 |
| Cash Profit Margin (%) | 26.80 | 25.99 | 27.09 | 31.10 | 31.38 |
| Performance Ratios | |||||
| ROA(%) | 8.59 | 8.25 | 7.69 | 9.17 | 10.77 |
| ROE(%) | 13.18 | 13.73 | 13.29 | 16.59 | 20.21 |
| ROCE(%) | 15.55 | 15.43 | 13.24 | 15.40 | 19.60 |
| Asset Turnover(x) | 0.59 | 0.57 | 0.51 | 0.49 | 0.53 |
| Sales/Fixed Asset(x) | 0.74 | 0.76 | 0.71 | 0.69 | 0.79 |
| Working Capital/Sales(x) | 4.29 | 2.58 | 2.67 | 3.24 | 27.41 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.35 | 1.31 | 1.40 | 1.46 | 1.26 |
| Receivable days | 50.73 | 59.21 | 68.92 | 73.02 | 66.84 |
| Inventory Days | 29.85 | 29.24 | 16.75 | 7.09 | 6.22 |
| Payable days | 1,652.80 | -2,132.64 | -4,008.24 | -3,357.42 | - |
| Valuation Parameters | |||||
| PER(x) | 55.31 | 51.39 | 60.44 | 53.68 | 23.45 |
| PCE(x) | 30.14 | 28.72 | 33.91 | 31.99 | 15.30 |
| Price/Book(x) | 6.73 | 6.72 | 7.45 | 7.92 | 4.52 |
| Yield(%) | 0.18 | 0.21 | 0.17 | - | - |
| EV/Net Sales(x) | 7.96 | 7.49 | 9.29 | 10.01 | 5.00 |
| EV/Core EBITDA(x) | 25.15 | 23.78 | 28.50 | 29.69 | 14.39 |
| EV/EBIT(x) | 41.60 | 37.43 | 47.58 | 44.00 | 18.25 |
| EV/CE(x) | 6.32 | 5.70 | 4.40 | 4.56 | 2.49 |
| M Cap / Sales | 8.09 | 7.47 | 9.19 | 9.95 | 4.80 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 9.26 | 22.61 | 19.22 | 8.57 | 10.20 |
| Core EBITDA Growth(%) | 9.92 | 18.42 | 15.28 | 5.28 | 14.32 |
| EBIT Growth(%) | 4.57 | 25.62 | 2.33 | -9.90 | 23.19 |
| PAT Growth(%) | 9.82 | 17.33 | -2.25 | -1.75 | 24.28 |
| EPS Growth(%) | 9.66 | 17.16 | -2.44 | -1.75 | -37.86 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.16 | 0.25 | 0.28 | 0.32 |
| Current Ratio(x) | 1.71 | 2.04 | 1.80 | 1.59 | 1.05 |
| Quick Ratio(x) | 1.52 | 1.76 | 1.65 | 1.55 | 1.03 |
| Interest Cover(x) | 14.15 | 14.13 | 21.10 | 17.94 | 15.94 |
| Total Debt/Mcap(x) | 0.01 | 0.02 | 0.03 | 0.04 | 0.07 |
Compare Financial Ratios of peers of SYNGENE INTERNATIONAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNGENE INTERNATIONAL | ₹29,732.7 Cr | -0.6% | -13.9% | -0.5% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹9,047.6 Cr | 5.2% | -12.6% | -6.8% | Stock Analytics | |
| JUST DIAL | ₹7,302.0 Cr | 1.8% | -19.1% | 7.7% | Stock Analytics | |
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,156.7 Cr | -2.1% | -21.4% | -57.8% | Stock Analytics | |
| DREAMFOLKS SERVICES | ₹2,054.1 Cr | 11.7% | -3.9% | -34.7% | Stock Analytics | |
| EKI ENERGY SERVICES | ₹650.9 Cr | 3.2% | -14.6% | -40.8% | Stock Analytics | |
SYNGENE INTERNATIONAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNGENE INTERNATIONAL | -0.6% |
-13.9% |
-0.5% |
| SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses
